Literature DB >> 19060458

Categorization of Skindex-29 scores using mixture analysis.

Tamar Nijsten1, Francesca Sampogna, Damiano Abeni.   

Abstract

BACKGROUND: Although the Skindex-29 is among the most commonly used health-related quality of life instruments in dermatology, the interpretation of obtained scores is not well documented.
OBJECTIVE: To create categories of the scores of the Skindex-29.
METHODS: The Skindex-29 scores of454 Italian patients with 6 distinct skin diseases from a specialized center were analyzed using mixture analyses. The validity of the obtained categorizations was tested.
RESULTS: Mixture analysis showed 4 distinct components (categories) for the emotion and functioning scale and 5 for the symptom scale. The total Skindex-29 score was categorized into 4 levels. As expected, patients with inflammatory diseases had higher levels of impairment, those with vitiligo and alopecia areata had low symptom levels and those with nevi were predominantly located in the lower categories for each of the scales.
CONCLUSION: The proposed categories of the Skindex-29 may ease the interpretation of obtained continuous scores. Copyright (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 19060458     DOI: 10.1159/000182253

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  13 in total

Review 1.  The Skindex instruments to measure the effects of skin disease on quality of life.

Authors:  Mary-Margaret Chren
Journal:  Dermatol Clin       Date:  2011-12-20       Impact factor: 3.478

2.  Interpretation of quality-of-life scores.

Authors:  Mary-Margaret Chren
Journal:  J Invest Dermatol       Date:  2010-05       Impact factor: 8.551

3.  Vascular Malformations and Health-Related Quality of Life: A Systematic Review and Meta-analysis.

Authors:  Henry L Nguyen; George F Bonadurer; Megha M Tollefson
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

4.  Quality of life in adults with facial port-wine stains.

Authors:  Solveig L Hagen; Katherine R Grey; Dorota Z Korta; Kristen M Kelly
Journal:  J Am Acad Dermatol       Date:  2016-12-09       Impact factor: 11.527

Review 5.  Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).

Authors:  Lisa G Rider; Victoria P Werth; Adam M Huber; Helene Alexanderson; Anand Prahalad Rao; Nicolino Ruperto; Laura Herbelin; Richard Barohn; David Isenberg; Frederick W Miller
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

6.  Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review.

Authors:  Arash Mostaghimi; Lynne Napatalung; Vanja Sikirica; Randall Winnette; Jason Xenakis; Samuel H Zwillich; Boris Gorsh
Journal:  Dermatol Ther (Heidelb)       Date:  2021-03-26

7.  Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review.

Authors:  Atrin Toussi; Virginia R Barton; Stephanie T Le; Oma N Agbai; Maija Kiuru
Journal:  J Am Acad Dermatol       Date:  2020-06-17       Impact factor: 15.487

8.  The Polish version of Skindex-29: psychometric properties of an instrument to measure quality of life in dermatology.

Authors:  Konrad Janowski; Stanisława Steuden; Bernarda Bereza
Journal:  Postepy Dermatol Alergol       Date:  2014-02-25       Impact factor: 1.837

9.  Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.

Authors:  Sheilagh Maguiness; Yemima Berman; Nathan Rubin; Melissa Dodds; Scott R Plotkin; Claire Wong; Christopher Moertel
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

10.  Patient-Reported Outcome Measures in Dermatology: A Systematic Review.

Authors:  Rachael L Pattinson; Nirohshah Trialonis-Suthakharan; Sunnia Gupta; Alasdair L Henry; Jacqueline F Lavallée; Marina Otten; Timothy Pickles; Nick Courtier; Jennifer Austin; Christine Janus; Matthias Augustin; Chris Bundy
Journal:  Acta Derm Venereol       Date:  2021-09-28       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.